Mohit Mazumder
Research Subjects
Mohit Mazumder has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Samudrala Gourinath
School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
11 shared publications - Elia Brodsky
Pine Biotech Inc., New Orleans, LA 70112, USA
7 shared publications - Harpreet Kaur
Department of Computational Biology, Indraprastha Institute of Information Technology
6 shared publications Samudrala Gourinath
School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
4 shared publications- Harsh Kumar
OmicsLogic Bioinformatics & Data Science India Private Limited, #6 CGHS Plot no 7, Sec-9 Dwarka, West Delhi - 110075, India
3 shared publications - Priyanka Dutta
National Centre for Cell Science, SP Pune University Campus
3 shared publications
Latest Publications
- Open Access
Genome-wide computational prediction of miRNAs encoded by influenza A virus (H3N2) predicts target genes involved in pulmonary and antiviral innate immunity
Influenza A virus (IAV) causes significant morbidity and mortality worldwide. Understanding how viral RNAs may regulate host genes through microRNA-like mechanisms can clarify pathogenesis and reveal therapeutic targets. In this study, we screened all eight IAV H3N2 RNA segments (PB2, PB1, PA, HA, NP, NA, M, and NS) using an ab initio computational pipeline; five segments (PB2, PB1, PA, HA, and M) met the VMir scoring threshold for further analysis, while NP, NA, and NS were excluded due to low pre-miRNA scores. Mature miRNAs were identified using MatureBayes, and target genes in the human genome were predicted with the miRDB server. From these targets, we selected two genes per qualifying segment (10 genes total) based on their functional relevance to influenza infection and supporting literature; all selected genes are unique to their respective segment. We identified 10 segment-specific target genes (IFNL1, DDX60, SAMHD1, MAVS, IRF4, BIRC2, AGO1, MAP3K1, NOD1, and TNFAIP1) and one common target across all five analyzed segments (CADM2). Gene Ontology and pathway analyses showed enrichment in interferon signaling, RIG-I-like receptor pathways, antiviral restriction, RNA interference, and inflammatory responses. Literature supports roles for these genes in pulmonary and antiviral innate immunity. Our findings provide a basis for experimental validation and may help the research community better understand influenza virus pathogenesis and identify novel therapeutic candidates. GRAPHICAL
Open AccessGenome-wide computational prediction of miRNAs encoded by influenza A virus (H3N2) predicts target genes involved in pulmonary and antiviral innate immunity
Influenza A virus (IAV) causes significant morbidity and mortality worldwide. Understanding how viral RNAs may regulate host genes through microRNA-like mechanisms can clarify pathogenesis and reveal therapeutic targets. In this study, we screened all eight IAV H3N2 RNA segments (PB2, PB1, PA, HA, NP, NA, M, and NS) using an ab initio computational pipeline; five segments (PB2, PB1, PA, HA, and M) met the VMir scoring threshold for further analysis, while NP, NA, and NS were excluded due to low pre-miRNA scores. Mature miRNAs were identified using MatureBayes, and target genes in the human genome were predicted with the miRDB server. From these targets, we selected two genes per qualifying segment (10 genes total) based on their functional relevance to influenza infection and supporting literature; all selected genes are unique to their respective segment. We identified 10 segment-specific target genes (IFNL1, DDX60, SAMHD1, MAVS, IRF4, BIRC2, AGO1, MAP3K1, NOD1, and TNFAIP1) and one common target across all five analyzed segments (CADM2). Gene Ontology and pathway analyses showed enrichment in interferon signaling, RIG-I-like receptor pathways, antiviral restriction, RNA interference, and inflammatory responses. Literature supports roles for these genes in pulmonary and antiviral innate immunity. Our findings provide a basis for experimental validation and may help the research community better understand influenza virus pathogenesis and identify novel therapeutic candidates. GRAPHICAL
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS)
- Vol. 3
Decoding the Tumor-Suppressive Landscape of Scavenger Receptor Class A Member 5: A Network-Based Analysis Linking Lipid Metabolism and Immuno Regulation in Breast Cancer
The tumor microenvironment plays a critical role in breast cancer progression, yet the contribution of stromal regulators remains incompletely understood. Here, we performed an integrative transcriptomic analysis to investigate the expression, functional associations, and clinical relevance of the scavenger receptor class A member 5 (SCARA5) in breast cancer. SCARA5 was consistently down-regulated across breast cancer subtypes relative to normal breast tissue. Diagnostic evaluation indicated moderate discriminatory ability between tumor and normal samples. Functional enrichment and network analyses associated SCARA5 with lipid metabolism and immune-related pathways. Single-cell and spatial transcriptomic analyses showed that SCARA5 expression is predominantly enriched in stromal fibroblasts and endothelial cells, with minimal expression in malignant epithelial cells, supporting its potential tumor-suppressive role in breast cancer. Clinically, SCARA5 expression was not significantly associated with overall survival in The Cancer Genome Atlas (TCGA) cohort but showed a significant association with progression-free interval after multivariate adjustment, while reduced expression was associated with adverse outcomes in independent validation cohorts. These findings suggest that SCARA5 is associated with stromal composition and immune-metabolic processes within the tumor microenvironment. However, as this study is based on correlative computational analyses, these results do not establish a causal role for SCARA5 in tumor progression. Further experimental validation is required to determine its mechanistic and clinical relevance.
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS)
- Vol. 3
Decoding the Tumor-Suppressive Landscape of Scavenger Receptor Class A Member 5: A Network-Based Analysis Linking Lipid Metabolism and Immuno Regulation in Breast Cancer
The tumor microenvironment plays a critical role in breast cancer progression, yet the contribution of stromal regulators remains incompletely understood. Here, we performed an integrative transcriptomic analysis to investigate the expression, functional associations, and clinical relevance of the scavenger receptor class A member 5 (SCARA5) in breast cancer. SCARA5 was consistently down-regulated across breast cancer subtypes relative to normal breast tissue. Diagnostic evaluation indicated moderate discriminatory ability between tumor and normal samples. Functional enrichment and network analyses associated SCARA5 with lipid metabolism and immune-related pathways. Single-cell and spatial transcriptomic analyses showed that SCARA5 expression is predominantly enriched in stromal fibroblasts and endothelial cells, with minimal expression in malignant epithelial cells, supporting its potential tumor-suppressive role in breast cancer. Clinically, SCARA5 expression was not significantly associated with overall survival in The Cancer Genome Atlas (TCGA) cohort but showed a significant association with progression-free interval after multivariate adjustment, while reduced expression was associated with adverse outcomes in independent validation cohorts. These findings suggest that SCARA5 is associated with stromal composition and immune-metabolic processes within the tumor microenvironment. However, as this study is based on correlative computational analyses, these results do not establish a causal role for SCARA5 in tumor progression. Further experimental validation is required to determine its mechanistic and clinical relevance.
- Open Access
Decoding the Tumor-Suppressive Landscape of SCARA5: A Network-Based Analysis Linking Lipid Metabolism and Immune Regulation in Breast Cancer
Background: The tumor microenvironment (TME) significantly impacts breast cancer progression, with stromal and immune components influencing tumor behavior. The scavenger receptor SCARA5 is recognized as a tumor suppressor in various cancers, but its role in breast cancer remains uncertain. Methods: We performed integrative transcriptomic analyses of bulk RNA-seq data from TCGA-BRCA, validated with GTEx, to investigate SCARA5 expression and its clinical significance. Differential expression, PAM50 subtype classification, PCA/t-SNE clustering, and ROC analyses were used to assess diagnostic potential. Functional enrichment (GO, KEGG, Reactome), PPI networks, and co-expression analyses explored pathways related to SCARA5. Single-cell transcriptomic datasets (TISCH2, Broad Portal) and spatial profiling (Human Protein Atlas) were employed to examine cellular and spatial localization. The prognostic importance was assessed using GEPIA2 survival analysis. Results: SCARA5 was significantly downregulated in breast tumors, especially in Her2-enriched and Luminal B subtypes, with ROC curves confirming its diagnostic importance. Enrichment and PPI analyses linked SCARA5 to lipid metabolism, immune regulation, and scavenger receptor pathways. Co-expression studies showed associations with lipid metabolism genes (FABP4, ADIPOQ, CD36) and immune-related genes (CLEC3B, LYVE1). Single-cell data indicated SCARA5 expression was limited to fibroblasts, endothelial cells, and immune subsets, with rare expression in malignant epithelial cells. Spatial analysis confirmed stromal enrichment, mainly in areas rich in fibroblasts and endothelial cells. Survival analysis demonstrated worse outcomes in patients with HER2+ and Luminal B breast cancers who had low SCARA5 expression. Conclusion: SCARA5 is a stromal-enriched gene with potential tumor-suppressive and immunometabolic regulatory roles in breast cancer. Its diagnostic and prognostic significance, especially in aggressive subtypes, highlights its potential as a biomarker and therapeutic target within the tumor stroma.
Open AccessDecoding the Tumor-Suppressive Landscape of SCARA5: A Network-Based Analysis Linking Lipid Metabolism and Immune Regulation in Breast Cancer
Background: The tumor microenvironment (TME) significantly impacts breast cancer progression, with stromal and immune components influencing tumor behavior. The scavenger receptor SCARA5 is recognized as a tumor suppressor in various cancers, but its role in breast cancer remains uncertain. Methods: We performed integrative transcriptomic analyses of bulk RNA-seq data from TCGA-BRCA, validated with GTEx, to investigate SCARA5 expression and its clinical significance. Differential expression, PAM50 subtype classification, PCA/t-SNE clustering, and ROC analyses were used to assess diagnostic potential. Functional enrichment (GO, KEGG, Reactome), PPI networks, and co-expression analyses explored pathways related to SCARA5. Single-cell transcriptomic datasets (TISCH2, Broad Portal) and spatial profiling (Human Protein Atlas) were employed to examine cellular and spatial localization. The prognostic importance was assessed using GEPIA2 survival analysis. Results: SCARA5 was significantly downregulated in breast tumors, especially in Her2-enriched and Luminal B subtypes, with ROC curves confirming its diagnostic importance. Enrichment and PPI analyses linked SCARA5 to lipid metabolism, immune regulation, and scavenger receptor pathways. Co-expression studies showed associations with lipid metabolism genes (FABP4, ADIPOQ, CD36) and immune-related genes (CLEC3B, LYVE1). Single-cell data indicated SCARA5 expression was limited to fibroblasts, endothelial cells, and immune subsets, with rare expression in malignant epithelial cells. Spatial analysis confirmed stromal enrichment, mainly in areas rich in fibroblasts and endothelial cells. Survival analysis demonstrated worse outcomes in patients with HER2+ and Luminal B breast cancers who had low SCARA5 expression. Conclusion: SCARA5 is a stromal-enriched gene with potential tumor-suppressive and immunometabolic regulatory roles in breast cancer. Its diagnostic and prognostic significance, especially in aggressive subtypes, highlights its potential as a biomarker and therapeutic target within the tumor stroma.
- Open Access
Distinct Transcriptomic Biomarkers and Pathways Associated with Cardiovascular and Neurovascular Dysregulation in Long COVID-19 Brain Fog
Background: Long COVID-19 often manifests as persistent cognitive impairments, commonly referred to as brain fog, with poorly understood biological mechanisms. Previous studies highlighted neuroinflammation and blood-brain barrier disruption. Here, we identify distinct biomarkers and dysregulated pathways, with a focus on cardiovascular and neurovascular involvement. Methods: We analyzed public RNA-sequencing data (GEO: GSE251849) comparing long COVID-19 patients with brain fog, long COVID-19 patients without cognitive symptoms, convalescent patients, and healthy controls. Differential gene expression, principal component analysis, and pathway enrichment analyses were performed using DESeq2, KEGG, GO, and Enrichr tools. Results: Our analysis revealed a distinct gene expression profile in patients with brain fog, identifying exclusive biomarkers such as NRCAM, GRIN2C, NOS2, and EDNRB. Pathway analysis revealed significant dysregulation in cardiovascular, calcium signaling, and relaxin signaling pathways, suggesting novel biological mechanisms that contribute to cognitive impairment. These findings expand beyond neuroinflammation and highlight potential cardiovascular involvement in long COVID-related cognitive dysfunction. Conclusion: Our study reveals novel transcriptomic signatures that highlight cardiovascular and neurovascular dysregulation, providing promising diagnostic biomarkers and therapeutic targets. Future research should validate these findings and investigate therapeutic interventions addressing these unique pathways.
Open AccessDistinct Transcriptomic Biomarkers and Pathways Associated with Cardiovascular and Neurovascular Dysregulation in Long COVID-19 Brain Fog
Background: Long COVID-19 often manifests as persistent cognitive impairments, commonly referred to as brain fog, with poorly understood biological mechanisms. Previous studies highlighted neuroinflammation and blood-brain barrier disruption. Here, we identify distinct biomarkers and dysregulated pathways, with a focus on cardiovascular and neurovascular involvement. Methods: We analyzed public RNA-sequencing data (GEO: GSE251849) comparing long COVID-19 patients with brain fog, long COVID-19 patients without cognitive symptoms, convalescent patients, and healthy controls. Differential gene expression, principal component analysis, and pathway enrichment analyses were performed using DESeq2, KEGG, GO, and Enrichr tools. Results: Our analysis revealed a distinct gene expression profile in patients with brain fog, identifying exclusive biomarkers such as NRCAM, GRIN2C, NOS2, and EDNRB. Pathway analysis revealed significant dysregulation in cardiovascular, calcium signaling, and relaxin signaling pathways, suggesting novel biological mechanisms that contribute to cognitive impairment. These findings expand beyond neuroinflammation and highlight potential cardiovascular involvement in long COVID-related cognitive dysfunction. Conclusion: Our study reveals novel transcriptomic signatures that highlight cardiovascular and neurovascular dysregulation, providing promising diagnostic biomarkers and therapeutic targets. Future research should validate these findings and investigate therapeutic interventions addressing these unique pathways.
- Open Access
Transcriptomic-Based Identification of FCRL6 as a Novel Diagnostic Biomarker in Diabetic Nephropathy
Diabetic nephropathy (DN) is a microvascular complication that arises in a sizable portion of individuals with diabetes mellitus, representing a growing public health issue given its progressive injury of the kidney. DN is primarily driven by the upregulation of pro-inflammatory markers and pathways, which cause hyperfiltration and significant physiological changes to the renal structure. To further understand the molecular mechanisms by which DN progresses, we used bioinformatics and meta-analysis techniques to analyze two datasets from the Gene Expression Omnibus (GEO) database: GSE142025 and GSE142153. Differential gene expressions (DGEs) were identified using the Bioconductor DESeq2 library and further used in functional enrichment analysis. DGEs were also constructed into protein-protein interaction networks and used to find regulatory hub genes. In total, 911 DGEs were found, and enrichment using the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) revealed strong correlations with immunoreactive responses and cascades. In our analysis, we discovered 12 protein-coding genes novel with regards to DN; we further identified Fc Receptor-Like 6 - FCRL6 - as a potential biomarker in nephropathy and described its involvement in the suppression of natural killer cell-mediated toxicity as a mechanism of poor immunoregulation in the diabetic kidney. The current study presents comparative analyses of the DN transcriptome and a possible diagnostic marker with applications in immunotherapy treatments of nephropathy.
Open AccessTranscriptomic-Based Identification of FCRL6 as a Novel Diagnostic Biomarker in Diabetic Nephropathy
Diabetic nephropathy (DN) is a microvascular complication that arises in a sizable portion of individuals with diabetes mellitus, representing a growing public health issue given its progressive injury of the kidney. DN is primarily driven by the upregulation of pro-inflammatory markers and pathways, which cause hyperfiltration and significant physiological changes to the renal structure. To further understand the molecular mechanisms by which DN progresses, we used bioinformatics and meta-analysis techniques to analyze two datasets from the Gene Expression Omnibus (GEO) database: GSE142025 and GSE142153. Differential gene expressions (DGEs) were identified using the Bioconductor DESeq2 library and further used in functional enrichment analysis. DGEs were also constructed into protein-protein interaction networks and used to find regulatory hub genes. In total, 911 DGEs were found, and enrichment using the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) revealed strong correlations with immunoreactive responses and cascades. In our analysis, we discovered 12 protein-coding genes novel with regards to DN; we further identified Fc Receptor-Like 6 - FCRL6 - as a potential biomarker in nephropathy and described its involvement in the suppression of natural killer cell-mediated toxicity as a mechanism of poor immunoregulation in the diabetic kidney. The current study presents comparative analyses of the DN transcriptome and a possible diagnostic marker with applications in immunotherapy treatments of nephropathy.
- Open Access
Global Analysis of Plasmodium falciparum Dihydropteroate Synthase Variants Associated with Sulfadoxine Resistance Reveals Variant Distribution and Mechanisms of Resistance: A Computational-Based Study
The continual rise in sulfadoxine (SDX) resistance affects the therapeutic efficacy of sulfadoxine-pyrimethamine; therefore, careful monitoring will help guide its prolonged usage. Mutations in Plasmodium falciparum dihydropteroate synthase (Pfdhps) are being surveilled, based on their link with SDX resistance. However, there is a lack of continuous analyses and data on the potential effect of molecular markers on the Pfdhps structure and function. This study explored single-nucleotide polymorphisms (SNPs) in Pfdhps that were isolated in Africa and other countries, highlighting the regional distribution and its link with structure. In total, 6336 genomic sequences from 13 countries were subjected to SNPs, haplotypes, and structure-based analyses. The SNP analysis revealed that the key SDX resistance marker, A437G, was nearing fixation in all countries, peaking in Malawi. The mutation A613S was rare except in isolates from the Democratic Republic of Congo and Malawi. Molecular docking revealed a general loss of interactions when comparing mutant proteins to the wild-type protein. During MD simulations, SDX was released from the active site in mutants A581G and A613S before the end of run-time, whereas an unstable binding of SDX to mutant A613S and haplotype A437A/A581G/A613S was observed. Conformational changes in mutant A581G and the haplotypes A581G/A613S, A437G/A581G, and A437G/A581G/A613S were seen. The radius of gyration revealed an unfolding behavior for the A613S, K540E/A581G, and A437G/A581G systems. Overall, tracking such mutations by the continuous analysis of Pfdhps SNPs is encouraged. SNPs on the Pfdhps structure may cause protein–drug function loss, which could affect the applicability of SDX in preventing malaria in pregnant women and children.
Open AccessGlobal Analysis of Plasmodium falciparum Dihydropteroate Synthase Variants Associated with Sulfadoxine Resistance Reveals Variant Distribution and Mechanisms of Resistance: A Computational-Based Study
The continual rise in sulfadoxine (SDX) resistance affects the therapeutic efficacy of sulfadoxine-pyrimethamine; therefore, careful monitoring will help guide its prolonged usage. Mutations in Plasmodium falciparum dihydropteroate synthase (Pfdhps) are being surveilled, based on their link with SDX resistance. However, there is a lack of continuous analyses and data on the potential effect of molecular markers on the Pfdhps structure and function. This study explored single-nucleotide polymorphisms (SNPs) in Pfdhps that were isolated in Africa and other countries, highlighting the regional distribution and its link with structure. In total, 6336 genomic sequences from 13 countries were subjected to SNPs, haplotypes, and structure-based analyses. The SNP analysis revealed that the key SDX resistance marker, A437G, was nearing fixation in all countries, peaking in Malawi. The mutation A613S was rare except in isolates from the Democratic Republic of Congo and Malawi. Molecular docking revealed a general loss of interactions when comparing mutant proteins to the wild-type protein. During MD simulations, SDX was released from the active site in mutants A581G and A613S before the end of run-time, whereas an unstable binding of SDX to mutant A613S and haplotype A437A/A581G/A613S was observed. Conformational changes in mutant A581G and the haplotypes A581G/A613S, A437G/A581G, and A437G/A581G/A613S were seen. The radius of gyration revealed an unfolding behavior for the A613S, K540E/A581G, and A437G/A581G systems. Overall, tracking such mutations by the continuous analysis of Pfdhps SNPs is encouraged. SNPs on the Pfdhps structure may cause protein–drug function loss, which could affect the applicability of SDX in preventing malaria in pregnant women and children.
- Open Access
- 30 September 2022
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 20 (3) , e32
Analysis of gene expression profiles to study malaria vaccine dose efficacy and immune response modulation
Malaria is a life-threatening disease, and Africa is still one of the most affected endemic regions despite years of policy to limit infection and transmission rates. Further, studies into the variable efficacy of the vaccine are needed to provide a better understanding of protective immunity. Thus, the current study is designed to delineate the effect of each dose of vaccine on the transcriptional profiles of subjects to determine its efficacy and understand the molecular mechanisms underlying the protection this vaccine provides. Here, we used gene expression profiles of pre and post-vaccination patients after various doses of RTS,S based on samples collected from the Gene Expression Omnibus datasets. Subsequently, differential gene expression analysis using edgeR revealed the significantly (false discovery rate < 0.005) 158 downregulated and 61 upregulated genes between control vs. controlled human malaria infection samples. Further, enrichment analysis of significant genes delineated the involvement of CCL8, CXCL10, CXCL11, XCR1, CSF3, IFNB1, IFNE, IL12B, IL22, IL6, IL27, etc., genes which found to be upregulated after earlier doses but downregulated after the 3rd dose in cytokine-chemokine pathways. Notably, we identified 13 cytokine genes whose expression significantly varied during three doses. Eventually, these findings give insight into the dual role of cytokine responses in malaria pathogenesis. The variations in their expression patterns after various doses of vaccination are linked to the protection as it decreases the severe inflammatory effects in malaria patients. This study will be helpful in designing a better vaccine against malaria and understanding the functions of cytokine response as well.
- 30 September 2022
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 20 (3) , e32
Open AccessAnalysis of gene expression profiles to study malaria vaccine dose efficacy and immune response modulation
Malaria is a life-threatening disease, and Africa is still one of the most affected endemic regions despite years of policy to limit infection and transmission rates. Further, studies into the variable efficacy of the vaccine are needed to provide a better understanding of protective immunity. Thus, the current study is designed to delineate the effect of each dose of vaccine on the transcriptional profiles of subjects to determine its efficacy and understand the molecular mechanisms underlying the protection this vaccine provides. Here, we used gene expression profiles of pre and post-vaccination patients after various doses of RTS,S based on samples collected from the Gene Expression Omnibus datasets. Subsequently, differential gene expression analysis using edgeR revealed the significantly (false discovery rate < 0.005) 158 downregulated and 61 upregulated genes between control vs. controlled human malaria infection samples. Further, enrichment analysis of significant genes delineated the involvement of CCL8, CXCL10, CXCL11, XCR1, CSF3, IFNB1, IFNE, IL12B, IL22, IL6, IL27, etc., genes which found to be upregulated after earlier doses but downregulated after the 3rd dose in cytokine-chemokine pathways. Notably, we identified 13 cytokine genes whose expression significantly varied during three doses. Eventually, these findings give insight into the dual role of cytokine responses in malaria pathogenesis. The variations in their expression patterns after various doses of vaccination are linked to the protection as it decreases the severe inflammatory effects in malaria patients. This study will be helpful in designing a better vaccine against malaria and understanding the functions of cytokine response as well.
- Open Access
In silico Analysis of Transcriptomic Profiling and Affected Biological pathways in Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease that is widely associated with Grey and white matter degradation due to the demyelination of axons. Thus exposing the underlying causes of this condition can lead to a novel treatment approach for Multiple Sclerosis. The total RNA microarray processed data from GEO for Multiple sclerotic patients was comprehensively analyzed to find out underlying differences between Grey Matter lesions (GML), Normal appearing Grey Matter (NAGM), and Control Grey matter at the transcriptomics level. Thus, in the current study, we performed various bioinformatics analyses on transcriptional profiles of 184 samples including 105 NAGM, 37 GML, and 42 Controls obtained from the NCBI-Bio project (PRJNA543111). First, exploratory data analysis based on gene expression data using principal component analysis (PCA) depicted distinct patterns between GML and CG samples. Subsequently, the Welch’s T-test differential gene expression analysis identified 15,525 significantly differentially expressed genes (p.adj value =+/-1.5) between these conditions. This study reveals the genes like CREB3L2 , KIF5B , WIPI1 , EP300 , NDUFA1 , ATG101 , AND TAF4 as the key features that may substantially contribute to loss of cognitive functions in Multiple sclerosis and several other neurodegenerative disorders. Further, this study also proposes genes associated with Huntington’s disease in Multiple sclerotic patients. Eventually, the results presented here reveal new insights into MS and how it affects the development of male primary sexual characteristics.
Open AccessIn silico Analysis of Transcriptomic Profiling and Affected Biological pathways in Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease that is widely associated with Grey and white matter degradation due to the demyelination of axons. Thus exposing the underlying causes of this condition can lead to a novel treatment approach for Multiple Sclerosis. The total RNA microarray processed data from GEO for Multiple sclerotic patients was comprehensively analyzed to find out underlying differences between Grey Matter lesions (GML), Normal appearing Grey Matter (NAGM), and Control Grey matter at the transcriptomics level. Thus, in the current study, we performed various bioinformatics analyses on transcriptional profiles of 184 samples including 105 NAGM, 37 GML, and 42 Controls obtained from the NCBI-Bio project (PRJNA543111). First, exploratory data analysis based on gene expression data using principal component analysis (PCA) depicted distinct patterns between GML and CG samples. Subsequently, the Welch’s T-test differential gene expression analysis identified 15,525 significantly differentially expressed genes (p.adj value =+/-1.5) between these conditions. This study reveals the genes like CREB3L2 , KIF5B , WIPI1 , EP300 , NDUFA1 , ATG101 , AND TAF4 as the key features that may substantially contribute to loss of cognitive functions in Multiple sclerosis and several other neurodegenerative disorders. Further, this study also proposes genes associated with Huntington’s disease in Multiple sclerotic patients. Eventually, the results presented here reveal new insights into MS and how it affects the development of male primary sexual characteristics.
- Open Access
Analysis of Gene Expression Profiles to study Malaria Vaccine Dose Efficacy & Immune Response Modulation
Malaria is a life-threatening disease, and the Africa is still one of the most affected endemic regions despite years of policy to limit infection and transmission rates. Further, studies into the variable efficacy of the vaccine are needed to provide a better understanding of protective immunity. Thus, the current study is designed to delineate the effect of the different vaccination doses on the transcriptional profiles of subjects to determine its efficacy and understand the molecular mechanisms underlying the protection this vaccine provides. Here, we used gene expression profiles of pre and post-vaccination patients after various doses of RTS,S based on 275 and 583 samples collected from the GEO datasets. At first, exploratory data analysis based Principal component analysis (PCA) shown the distinct pattern of different doses. Subsequently, differential gene expression analysis using edgeR revealed the significantly (FDR CCL8 , CXCL10 , CXCL11 , XCR1 , CSF3 , IFNB1 , IFNE , IL12B , IL22 , IL6 , IL27 , etc.,genes which found to be upregulated after earlier doses but downregulated after the 3 rd dose in cytokine-chemokine pathways. Notably, we identified 13 cytokine genes whose expression significantly varied during three doses. Eventually, these findings give insight to the dual role of cytokine responses in malaria pathogenesis and variations in their expression patterns after various doses of vaccination involved in protection.
Open AccessAnalysis of Gene Expression Profiles to study Malaria Vaccine Dose Efficacy & Immune Response Modulation
Malaria is a life-threatening disease, and the Africa is still one of the most affected endemic regions despite years of policy to limit infection and transmission rates. Further, studies into the variable efficacy of the vaccine are needed to provide a better understanding of protective immunity. Thus, the current study is designed to delineate the effect of the different vaccination doses on the transcriptional profiles of subjects to determine its efficacy and understand the molecular mechanisms underlying the protection this vaccine provides. Here, we used gene expression profiles of pre and post-vaccination patients after various doses of RTS,S based on 275 and 583 samples collected from the GEO datasets. At first, exploratory data analysis based Principal component analysis (PCA) shown the distinct pattern of different doses. Subsequently, differential gene expression analysis using edgeR revealed the significantly (FDR CCL8 , CXCL10 , CXCL11 , XCR1 , CSF3 , IFNB1 , IFNE , IL12B , IL22 , IL6 , IL27 , etc.,genes which found to be upregulated after earlier doses but downregulated after the 3 rd dose in cytokine-chemokine pathways. Notably, we identified 13 cytokine genes whose expression significantly varied during three doses. Eventually, these findings give insight to the dual role of cytokine responses in malaria pathogenesis and variations in their expression patterns after various doses of vaccination involved in protection.
- Open Access
- 6 June 2021
- Published by Wiley in The FEBS Journal
- Vol. 288 (22) , 6492-6509
Functional implications of residues of the B′ motif of geminivirus replication initiator protein in its helicase activity
Geminivirus replication initiator protein (Rep) is a multifunctional viral protein required for replication. During the process of viral replication, Rep acts as a site‐ and strand‐specific endonuclease, ligase, ATPase, and helicase. B' motif and β‐hairpin loop of the geminivirus Rep are conserved and important for Rep‐mediated helicase activity required for viral replication. To dissect the roles of various amino acid residues of the B' motif and β‐hairpin loop of the geminivirus Rep helicase in its process of unwinding DNA, we investigated eight conserved residues near the ATP active site or the ssDNA contact channel. Our strategy was to mutate these residues to alanines and investigate the effects of these mutations on various biochemical activities associated with DNA unwinding. We looked into the ATP binding, ATP hydrolysis, DNA binding, and DNA unwinding activities of the wild‐type and mutant Rep proteins. These investigations showed four residues (Arg279, Asp280, Tyr287, and Pro290) affecting the DNA unwinding activity. A structural model analysis confirmed the B' loop and ssDNA binding loop to be connected through a β‐hairpin structure, suggesting that changes on one loop might affect the other and that these residues function by acting in concert. Viral genomes containing Rep proteins having these mutations in the B' motif did not replicate in planta. Taken together, these results indicated all four residues to be implicated in helicase activity mediated by Rep and demonstrated the significance, for viral replication, of the B' motif and β‐hairpin loop of the C‐terminal region of the Rep protein.
- 6 June 2021
- Published by Wiley in The FEBS Journal
- Vol. 288 (22) , 6492-6509
Open AccessFunctional implications of residues of the B′ motif of geminivirus replication initiator protein in its helicase activity
Geminivirus replication initiator protein (Rep) is a multifunctional viral protein required for replication. During the process of viral replication, Rep acts as a site‐ and strand‐specific endonuclease, ligase, ATPase, and helicase. B' motif and β‐hairpin loop of the geminivirus Rep are conserved and important for Rep‐mediated helicase activity required for viral replication. To dissect the roles of various amino acid residues of the B' motif and β‐hairpin loop of the geminivirus Rep helicase in its process of unwinding DNA, we investigated eight conserved residues near the ATP active site or the ssDNA contact channel. Our strategy was to mutate these residues to alanines and investigate the effects of these mutations on various biochemical activities associated with DNA unwinding. We looked into the ATP binding, ATP hydrolysis, DNA binding, and DNA unwinding activities of the wild‐type and mutant Rep proteins. These investigations showed four residues (Arg279, Asp280, Tyr287, and Pro290) affecting the DNA unwinding activity. A structural model analysis confirmed the B' loop and ssDNA binding loop to be connected through a β‐hairpin structure, suggesting that changes on one loop might affect the other and that these residues function by acting in concert. Viral genomes containing Rep proteins having these mutations in the B' motif did not replicate in planta. Taken together, these results indicated all four residues to be implicated in helicase activity mediated by Rep and demonstrated the significance, for viral replication, of the B' motif and β‐hairpin loop of the C‐terminal region of the Rep protein.